Reiter’s Syndrome Following Intravesical Bacillus Calmette- ‑Guérin Immunotherapy for Bladder Carcinoma in situ
Intravesical Bacillus Calmette-Guérin (BCG) immunotherapy after transurethral resection of non-muscle-invasive bladder cancer has been proven to reduce the recurrence and progression of the disease. Unfortunately, the treatment is associated with adverse effects that can induce other chronic heal...
Saved in:
| Main Authors: | , , , |
|---|---|
| Format: | Artigo |
| Language: | Inglês |
| Published: |
Sestre Milosrdnice University hospital, Institute of Clinical Medical Research
2026-01-01
|
| Series: | Acta Clinica Croatica |
| Subjects: | |
| Online Access: | https://hrcak.srce.hr/file/501877 |
| Tags: |
No Tags, Be the first to tag this record!
|